Seeking Alpha

ESPR
  Esperion Therapeutics - NASDAQ

8/21/2014, 7:18 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ESPR vs. ETF Alternatives
Company Description
Esperion Therapeutics Inc is engaged in the research, development and commercialization of therapies for the treatment of patients with elevated levels of elevated levels of LDL-C.
Sector: Healthcare
Industry: Biotechnology
Country: United States